Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 28, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

December 31, 2027

Conditions

AL Amyloidosis

Interventions

DRUG

Teclistamab (Tec)

Teclistamab will be administered via a subcutaneous injection

Trial Locations (1)

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER